INDOUS — Indo US Bio-Tech Balance Sheet
0.000.00%
Last trade - 00:00- IN₹1.78bn
- IN₹2.08bn
- IN₹1.10bn
Annual balance sheet for Indo US Bio-Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.492 | 1.9 | 11 | 10 | 69.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 234 | 328 | 202 | 150 | 138 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 468 | 599 | 731 | 867 | 1,207 |
| Net Property, Plant And Equipment | 78.8 | 87.3 | 105 | 102 | 117 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 556 | 695 | 845 | 978 | 1,331 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 123 | 123 | 175 | 163 | 395 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 171 | 150 | 217 | 193 | 406 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 385 | 545 | 627 | 785 | 925 |
| Total Liabilities & Shareholders' Equity | 556 | 695 | 845 | 978 | 1,331 |
| Total Common Shares Outstanding |